Clinical Trial Update: Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of combining Biphasic Insulin Aspart 30 with Metformin in patients with Type 2 diabetes inadequately controlled with basal in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2010-07-05